Molecular Mechanism of Viral Resistance to a Potent Non-nucleoside Inhibitor Unveiled by Molecular Simulations

Abstract

Recently, we reported on a potent benzimidazole derivative (227G) that inhibits the growth of the bovine viral diarrhea virus (BVDV) in cell-based and enzyme assays at nanomolar concentrations. The target of 227G is the viral RNA-dependent RNA polymerase (RdRp), and the I261M mutation located in motif I of the RdRp finger domain was found to induce drug resistance. Here we propose a molecular mechanism for the retained functionality of the enzyme in the presence of the inhibitor, on the basis of a thorough computational study of the apo and holo forms of the BVDV RdRp either in the wild type (wt) or in the form carrying the I261M mutation. Our study shows that although the mutation affects to some extent the structure of the apoenzyme, the functional dynamics of the protein appear to be largely maintained, which is consistent with the retained functionality of this natural mutant. Despite the binding site of 227G not collapsing or undergoing drastic structural changes upon introduction of the I261M substitution, these alterations reflect crucially on the binding mode of 227G, which is significantly different from that found in wt RdRp. In particular, while in the wt system the four loops lining the template entrance site embrace 227G and close the template passageway, in the I261M variant the template entrance is only marginally occluded, allowing in principle the translocation of the template to the interior of the enzyme. In addition, the mutated enzyme in the presence of 227G retains several characteristics of the wt apoprotein. Our work provides an original molecular picture of a resistance mechanism that is consistent with published experimental data.

Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach

“…All the images were generated using VMD and Schrodinger Suite (Asthana et al, 2014(Asthana et al, , 2015Humphrey et al, 1996) and graphs were plotted using XMGRACE (Mittal et al, 2019;Turner, 2005).…”

A combined in silico / in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems

“…1) that inhibits, in cell-based assays, both BVDV and HCV replication in the low micromolar range (EC 50 values of 0.80 and 1.11 µM, respectively) [18]. The molecular target was identified in the viral RNA dependent RNA polymerase (RdRp) [19] and dose−response curves indicate that 227G potently inhibits (IC 50 =0.0020 ± 0.0004 µM) the BVDV RdRp activity [20]. In an attempt to widen the knowledge on the anti BVDV activity of nitrogen-containing heterocyclic compounds we complicate the bicyclic system and we synthesized a series of [4,7]phenantroline derivatives [21] (Fig.…”

A Multidimensional Approach to Explore the Use of a Small Heterobifunctional Crosslinker based on a Metabolite of the Kynurenine Pathway

“…The optimization was done using the OPLS3 force field [33]. To check the activity of III and to find its binding site as the co-crystal is absent, the blind docking studies were performed [34][35][36][37]. It was done using AUTODOCK4.2 [38].…”